Related Experiment Video
Updated: Jul 1, 2026

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
Published on: August 6, 2020
Neonatal vaccination of low birthweight infants in Ghana
Maureen O'Leary1, Karen Edmond2, Sian Floyd1
1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Insights
Low birth weight (LBW) infants are significantly underserved by neonatal BCG vaccination, highlighting a critical gap in global immunization equity. Improving vaccination practices at healthcare facilities is essential for timely and equitable BCG coverage.
Area of Science:
- Public Health
- Immunology
- Neonatal Care
Background:
- Global vaccination policies aim to enhance equity and uptake by identifying underserved populations.
- Neonatal BCG vaccination is crucial for protecting infants against severe forms of tuberculosis.
- Understanding determinants of vaccination is key to improving coverage, especially for vulnerable infants.
Purpose of the Study:
- To investigate birth weight as a determinant of neonatal BCG vaccination.
- To identify infants underserved by neonatal BCG vaccination.
- To assess the impact of place of delivery and infant illness on BCG vaccination disparities.
Main Methods:
- Logistic regression analysis was used to calculate adjusted odds ratios (AORs).
- Association between low birth weight (LBW) categories and non-vaccination with BCG was examined.
- Data included birth weight, place of delivery, infant illness, and BCG vaccination status up to 27 days.
Main Results:
- A significant dose-response relationship exists between LBW and delayed/missed neonatal BCG vaccination (p-trend<0.0001).
- Infants weighing 1.50-1.99 kg (AOR 1.64) and <1.50 kg (AOR 2.42) had higher odds of non-vaccination compared to non-LBW infants.
- Facility-born infants received BCG vaccination at a mean of 6 days, indicating delayed vaccination post-discharge.
Conclusions:
- Low birth weight is a significant risk factor for under-vaccination in the neonatal period, even for facility-born infants.
- Ensuring BCG vaccination at the time of facility birth would substantially improve vaccination timing and equity.
- Targeting LBW infants and improving in-facility vaccination protocols are crucial for equitable BCG coverage.
Objectives:
Global vaccination policy advocates for identifying and targeting groups who are underserved by vaccination to increase equity and uptake. We investigated whether birth weight and other factors are determinants of neonatal BCG vaccination in order to identify infants underserved by vaccination.
Methods:
We used logistic regression to calculate adjusted ORs (AORs) for the association between birth weight (categorised as non-low birth weight (NLBW) (≥2.50 kg) and low birth weight (LBW) (2-2.49 kg, 1.50-1.99 kg and <1.50 kg)) and non-vaccination with BCG at the end of the neonatal period (0-27 days). We assessed whether this association varied by place of delivery and infant illness. We calculated how BCG timing and uptake would improve by ensuring the vaccination of all facility-born infants prior to discharge.
Results:
There was a strong dose-response relationship between LBW and not receiving BCG in the neonatal period (p-trend<0.0001). Infants weighing 1.50-1.99 kg had odds of non-vaccination 1.6 times (AOR 1.64; 95% CI 1.30 to 2.08), and those weighing <1.50 kg 2.4 times (AOR 2.42; 95% CI 1.50 to 3.88) those of NLBW infants. Other determinants included place of delivery, distance to the health facility and socioeconomic status. Neither place of delivery nor infant illness modified the association between birth weight and vaccination (p-interaction all >0.19). Facility-born infants were vaccinated at a mean of 6 days, suggesting that they were not vaccinated in the facility at birth but were referred for vaccination.
Conclusions:
LBW is a risk factor for neonatal under-vaccination, even for facility-born infants. Ensuring vaccination at facility births would substantively improve timing and equitable BCG vaccination.
Related Concept Videos
Vaccinations
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Drug Dosing: Infants and Children
Vaccines